Patent approvals: November 2017

November has seen several interesting patent approvals and MedChemNet has assembled a round-up of a few of the most interesting in relation to medicinal chemistry.

Go to the profile of RxNet
Dec 19, 2017
0
0

In our new series of posts, in collaboration with our sister journal Pharmaceutical Patent Analyst, we will highlight interesting granted patents of the past month in relation to medicinal chemistry.

If you enjoy content like this, don't forget to have a look at our patent approvals from August and October 2017. 

Patent name:  LSD1 INHIBITORS
Patent number:  US 9,809,541 B2
Inventors:  Matthew Arnold Marx, San Diego, CA (US); Arkadii Vaisburg, Kirkland (CA); James Gail Christensen, San Diego, CA (US); and Robert Anthony Galemmo, Jr., San Francisco, CA (US)
Assigned to:  Mirati Therapeutics, Inc., San Diego, CA (US)
Date of assignment: November 7, 2017

More information


Patent name:  FACTOR XIA INHIBITORS
Patent number:  US 9,809,545 B2
Inventors:  Anthony Ogawa, New Providence, NJ (US); Scott Edmondson, Clark, NJ (US); Mark Erion, Mountainside, NJ (US); Santhosh Neelamkavil, Edison, NJ (US); Zhuyan Guo, Scotch Plains, NJ (US); Rudrajit Mal, Edison, NJ (US); Jiafang He, South Brunswick, NJ (US); Weiguo Liu, Princeton, NJ (US); and Ellen K. Vande Bunte, Hawthorne, NJ (US)
Assigned to:  Merck Sharp & Dohme Corp., Rahway, NJ (US)
Date of assignment: November 7, 2017

More information


Patent name:  METFORMIN SALTS TO TREAT TYPE2 DIABETES
Patent number:  US 9,815,777 B2
Inventors:  Om P Goel, Ann Arbor, MI (US)
Assigned to:  Jiva Pharma, Inc., Ann Arbor, MI (US)
Date of assignment: November 14, 2017

More information

Patent name:  NMDA ANTAGONIST PRODRUGS
Patent number:  US 9,822,075 B2
Inventors:  Gunnar Nordvall, Rönninge (SE); Katharina Hogdin, Knivsta (SE); Per Jonas Malmborg, Linköping (SE); Annika Kers, Malmö (SE); Dirk Reinhold Weigelt, Rönninge (SE); Peter Robert Bernstein, Rose Valley, PA (US); Michael Quirk, Acton, MA (US); and Michael Balestra, New Fairfield, CT (US)
Assigned to:  AstraZeneca AB, Södertälje (SE)
Date of assignment: November 21, 2017

More information


Patent name:  COMPOUNDS FOR THE TREATMENT OF INFLUENZA
Patent number:  US 9,828,333 B2
Inventors:  Bernd Clement, Kiel (DE); Joscha Kotthaus, Kiel (DE); Jurke Kotthaus, Kiel (DE); and Dennis Schade, La Jolla, CA (US)
Assigned to:  CHRISTIAN-ALBRECHTS-UNIVERSITAT ZU KIEL, (DE)
Date of assignment: November 28, 2017

More information


Patent name:  INHIBITORS OF THE NOTCH SIGNALING PATHWAY AND SECRETION FOR USE IN MEDICINE
Patent number:  US 9,828,344 B2
Inventors:  Christoph Kaether, Jena (DE); and Andreas Krämer, Jena (DE)
Assigned to:  LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT E.V. (FLI), Jena (DE)
Date of assignment: November 28, 2017

More information

 

 

Source: www.uspto.gov/learning-and-resources/official-gazette/official-gazette-patents

Go to the profile of RxNet

RxNet

A network for the drug discovery and development community, Future Science Group

Your source for the latest news and views from the fields of drug discovery and medicinal chemistry.

No comments yet.